Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach.

Am J Cardiovasc Drugs · 2022 · PMC9468081 · PMID 35316483

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The improvement in clinical outcomes did not reach statistical significance at 1 month, but adenosine reduced MACE rate at 1 year and was associated with less left ventricular (LV) negative remodeling [ 48 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.